The tumor necrosis factor type 2 receptor plays a protective role in tumor necrosis factor-α-induced bone resorption lacunae on mouse calvariae

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 6, 2011, Pages 671-681

  Nagano, Kenichi ^a   Alles, Neil ^a,b   Mian, Anower Hussain ^c   Shimoda, Asako ^a   Morimoto, Nobuyuki ^d   Tamura, Yukihiko ^a   Shimokawa, Hitoyata ^a   Akiyoshi, Kazunari ^a,e   Ohya, Keiichi ^a   Aoki, Kazuhiro ^a  

^a Tokyo Medical and Dental University ^*  (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c City Dental College and Hospital   (Bangladesh)

^d TOHOKU UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Bone resorption lacunae; Cholesterol bearing pullulan; Human TNF ; Mouse TNF ; TNF type 2 receptor

Indexed keywords

NANOPARTICLE; OSTEOCLAST DIFFERENTIATION FACTOR; PULLULAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CALVARIA; CONTROLLED STUDY; CYTOKINE RELEASE; GEL; GENE SEQUENCE; HETEROZYGOTE; IN VIVO STUDY; MORPHOMETRICS; MOUSE; NANOENCAPSULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; BONE DENSITY; BONE RESORPTION; GLUCANS; HUMANS; MICE; MICE, MUTANT STRAINS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKULL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83055194715     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-011-0270-z     Document Type: Article

References (49)

1. DR Haynes 2004 Bone lysis and inflammation Inflamm Res 53 596 600 15693607 10.1007/s00011-004-1303-z 1:CAS:528:DC%2BD2cXhtVKlsL3N (Pubitemid 40385317)
2. T Takeuchi H Yamanaka E Inoue H Nagasawa M Nawata K Ikari K Saito N Sekiguchi E Sato H Kameda S Iwata T Mochizuki K Amano Y Tanaka 2008 Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J) Mod Rheumatol 18 447 454 18493716 10.1007/s10165-008-0077-5 1:CAS:528:DC%2BD1cXht1anu7rE
3. Y Mayer A Balbir-Gurman EE Machtei 2009 Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis J Periodontol 80 1414 1420 19722791 10.1902/jop.2009.090015 1:CAS:528: DC%2BD1MXht1eru7bI
4. EH Choy GS Panayi 2001 Cytokine pathways and joint inflammation in rheumatoid arthritis N Engl J Med 344 907 916 11259725 10.1056/ NEJM200103223441207 1:CAS:528:DC%2BD3MXisFyrur8%3D (Pubitemid 32224400)
5. DT Graves D Cochran 2003 The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction J Periodontol 74 391 401 12710761 10.1902/jop.2003.74.3.391 1:CAS:528:DC%2BD3sXlvFCjtbs%3D (Pubitemid 36939356)
6. K Kobayashi N Takahashi E Jimi N Udagawa M Takami S Kotake N Nakagawa M Kinosaki K Yamaguchi N Shima H Yasuda T Morinaga K Higashio TJ Martin T Suda 2000 Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J Exp Med 191 275 286 10637272 10.1084/jem.191.2.275 1:CAS:528:DC%2BD3cXntFenug%3D%3D (Pubitemid 30060917)
7. Y Azuma K Kaji R Katogi S Takeshita A Kudo 2000 Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts J Biol Chem 275 4858 4864 10671521 10.1074/jbc.275.7.4858 1:CAS:528: DC%2BD3cXhsVyms74%3D (Pubitemid 30108878)
8. SD Yogesha SM Khapli RK Srivastava LS Mangashetti ST Pote GC Mishra MR Wani 2009 IL-3 inhibits TNF-alpha-induced bone resorption and prevents inflammatory arthritis J Immunol 182 361 370 19109167 1:CAS:528: DC%2BD1cXhsFCisL7M
9. H Saito T Kojima M Takahashi WC Horne R Baron T Amagasa K Ohya K Aoki 2007 A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis Arthritis Rheum 56 1164 1174 17393436 10.1002/art.22495 1:CAS:528:DC%2BD2sXltFKgsrc%3D (Pubitemid 46608641)
10. S Gupta 2001 Molecular steps of tumor necrosis factor receptor-mediated apoptosis Curr Mol Med 1 317 324 11899080 10.2174/1566524013363780 1:CAS:528:DC%2BD3MXltFGlurk%3D (Pubitemid 33772960)
11. G Kollias E Douni G Kassiotis D Kontoyiannis 1999 On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease Immunol Rev 169 175 194 10450517 10.1111/j.1600-065X.1999.tb01315.x 1:CAS:528:DyaK1MXltlOgsLo%3D (Pubitemid 29338732)
12. H Wajant K Pfizenmaier P Scheurich 2003 Tumor necrosis factor signaling Cell Death Differ 10 45 65 12655295 10.1038/sj.cdd.4401189 1:CAS:528: DC%2BD3sXit12mu7s%3D (Pubitemid 36511832)
13. Kollias G (2005) TNF pathophysiology in murine models of chronic inflammation and autoimmunity. Semin Arthritis Rheum 34:3-6
14. Y Abu-Amer FP Ross J Edwards SL Teitelbaum 1997 Lipopolysaccharide- stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor J Clin Invest 100 1557 1565 9294124 10.1172/JCI119679 1:CAS:528:DyaK2sXmt1Cqtrw%3D (Pubitemid 27425783)
15. A Hussain Mian H Saito N Alles H Shimokawa K Aoki K Ohya 2008 Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo J Bone Miner Metab 26 469 477 18758905 1:CAS:528:DC%2BD1cXhtVGnsL7K
16. C Bossen K Ingold A Tardivel JL Bodmer O Gaide S Hertig C Ambrose J Tschopp P Schneider 2006 Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human J Biol Chem 281 13964 13971 16547002 10.1074/jbc.M601553200 1:CAS:528:DC%2BD28XksFeisr0%3D (Pubitemid 43848322)
17. LA Tartaglia DV Goeddel 1992 Two TNF receptors Immunol Today 13 151 153 1322675 10.1016/0167-5699(92)90116-O 1:CAS:528:DyaK38XltV2nu7k%3D
18. M Lewis LA Tartaglia A Lee GL Bennett GC Rice GH Wong EY Chen DV Goeddel 1991 Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific Proc Natl Acad Sci USA 88 2830 2834 1849278 10.1073/pnas.88.7.2830 1:CAS:528:DyaK3MXlslKgs7g%3D (Pubitemid 21916513)
19. T Nishikawa K Akiyoshi J Sunamoto 1996 Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides J Am Chem Soc 118 6110 6115 10.1021/ja953843c 1:CAS:528:DyaK28XjsFCisrs%3D (Pubitemid 26236845)
20. T Shimizu T Kishida U Hasegawa Y Ueda J Imanishi H Yamagishi K Akiyoshi E Otsuji O Mazda 2008 Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy Biochem Biophys Res Commun 367 330 335 18158918 10.1016/j.bbrc.2007.12.112 1:CAS:528:DC%2BD1cXpsFynsw%3D%3D
21. K Akiyoshi S Deguchi N Moriguchi S Yamaguchi J Sunamoto 1993 Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles Macromolecules 26 3062 3068 10.1021/ma00064a011 1:CAS:528:DyaK3sXksV2ktb4%3D (Pubitemid 23692851)
22. Y Suzuki K Aoki H Saito M Umeda H Nitta R Baron K Ohya 2006 A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice J Periodont Res 41 81 91 16499710 10.1111/j.1600-0765.2005.00812.x 1:CAS:528:DC%2BD28XjslSqt78%3D (Pubitemid 43341280)
23. Soysa NS, Alles N, Weih D, Lovas A, Mian AH, Shimokawa H, Yasuda H, Weih F, Jimi E, Ohya K, Aoki K (2010) The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J Bone Miner Res 25:809-818
24. T Koga Y Matsui M Asagiri T Kodama B de Crombrugghe K Nakashima H Takayanagi 2005 NFAT and Osterix cooperatively regulate bone formation Nat Med 11 880 885 16041384 10.1038/nm1270 1:CAS:528:DC%2BD2MXmvFemsL0%3D (Pubitemid 41161121)
25. K Aoki E Didomenico NA Sims K Mukhopadhyay L Neff A Houghton M Amling JB Levy WC Horne R Baron 1999 The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice Bone (NY) 25 261 267 1:CAS:528:DyaK1MXls1WiurY%3D (Pubitemid 29406051)
26. N Tomomatsu K Aoki N Alles NS Soysa A Hussain H Nakachi S Kita H Shimokawa K Ohya T Amagasa 2009 LPS-induced inhibition of osteogenesis is TNF-alpha dependent in a murine tooth extraction model J Bone Miner Res 24 1770 1781 19419299 10.1359/jbmr.090410 1:CAS:528:DC%2BD1MXhtlGgurfF
27. H Kitaura MS Sands K Aya P Zhou T Hirayama B Uthgenannt S Wei S Takeshita DV Novack MJ Silva Y Abu-Amer FP Ross SL Teitelbaum 2004 Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo J Immunol 173 4838 4846 15470024 1:CAS:528: DC%2BD2cXotFCqtLs%3D (Pubitemid 39387764)
28. H Kitaura P Zhou HJ Kim DV Novack FP Ross SL Teitelbaum 2005 M-CSF mediates TNF-induced inflammatory osteolysis J Clin Invest 115 3418 3427 16294221 10.1172/JCI26132 1:CAS:528:DC%2BD2MXhtlSqtLrO (Pubitemid 43121830)
29. M Yoshimatsu H Kitaura Y Fujimura T Eguchi H Kohara Y Morita N Yoshida 2009 IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo Bone (NY) 45 1010 1016 1:CAS:528: DC%2BD1MXhtFyjsr%2FL
30. HJ Kim EJ Chang HM Kim SB Lee HD Kim G Su Kim HH Kim 2006 Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha Free Radic Biol Med 40 1483 1493 16632109 10.1016/j.freeradbiomed. 2005.10.066 1:CAS:528:DC%2BD28Xjsl2mtbg%3D
31. PW Dempsey SE Doyle JQ He G Cheng 2003 The signaling adaptors and pathways activated by TNF superfamily Cytokine Growth Factor Rev 14 193 209 12787559 10.1016/S1359-6101(03)00021-2 1:CAS:528:DC%2BD3sXkt1Ghsro%3D (Pubitemid 36693141)
32. X Feng 2005 Regulatory roles and molecular signaling of TNF family members in osteoclasts Gene (Amst) 350 1 13 10.1016/j.gene.2005.01.014 1:CAS:528:DC%2BD2MXjtFOlsLo%3D
33. J Hauer S Puschner P Ramakrishnan U Simon M Bongers C Federle H Engelmann 2005 TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs Proc Natl Acad Sci USA 102 2874 2879 15708970 10.1073/pnas.0500187102 1:CAS:528:DC%2BD2MXitVSksbg%3D (Pubitemid 40299884)
34. M Rothe V Sarma VM Dixit DV Goeddel 1995 TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 Science 269 1424 1427 7544915 10.1126/science.7544915 1:CAS:528:DyaK2MXnvFCkt74%3D
35. HY Song CH Regnier CJ Kirschning DV Goeddel M Rothe 1997 Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 Proc Natl Acad Sci USA 94 9792 9796 9275204 10.1073/pnas.94.18.9792 1:CAS:528:DyaK2sXlvVWms7k%3D (Pubitemid 27408143)
36. K Kanazawa A Kudo 2005 TRAF2 is essential for TNF-alpha-induced osteoclastogenesis J Bone Miner Res 20 840 847 15824857 10.1359/JBMR.041225 1:CAS:528:DC%2BD2MXnt1ymsL8%3D (Pubitemid 40571641)
37. K Kanazawa Y Azuma H Nakano A Kudo 2003 TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis J Bone Miner Res 18 443 450 12619928 10.1359/jbmr.2003.18.3.443 1:CAS:528:DC%2BD3sXitVyrs7o%3D (Pubitemid 36241060)
38. B Zarnegar S Yamazaki JQ He G Cheng 2008 Control of canonical NF-kappaB activation through the NIK-IKK complex pathway Proc Natl Acad Sci USA 105 3503 3508 18292232 10.1073/pnas.0707959105 1:CAS:528:DC%2BD1cXjtlamsro%3D (Pubitemid 351723582)
39. J Lam S Takeshita JE Barker O Kanagawa FP Ross SL Teitelbaum 2000 TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand J Clin Invest 106 1481 1488 11120755 10.1172/JCI11176 1:CAS:528:DC%2BD3cXovFagtbo%3D (Pubitemid 32038586)
40. J Pfeilschifter C Chenu A Bird GR Mundy GD Roodman 1989 Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro J Bone Miner Res 4 113 118 2785743 10.1002/jbmr.5650040116 1:CAS:528:DyaL1MXhvFSrsrY%3D (Pubitemid 19079131)
41. BM Thomson GR Mundy TJ Chambers 1987 Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption J Immunol 138 775 779 3805716 1:CAS:528:DyaL2sXhtVSltLY%3D (Pubitemid 17012392)
42. YH Zhang A Heulsmann MM Tondravi A Mukherjee Y Abu-Amer 2001 Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways J Biol Chem 276 563 568 11032840 10.1074/jbc.M008198200 1:CAS:528:DC%2BD3MXmtFSquw%3D%3D (Pubitemid 32050352)
43. H Rauert A Wicovsky N Muller D Siegmund V Spindler J Waschke C Kneitz H Wajant 2010 Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2) J Biol Chem 285 7394 7404 20038584 10.1074/jbc.M109.037341 1:CAS:528:DC%2BC3cXisFaksL0%3D
44. S Zenger B Ek-Rylander G Andersson 2010 Long bone osteoclasts display an augmented osteoclast phenotype compared to calvarial osteoclasts Biochem Biophys Res Commun 394 743 749 20230792 10.1016/j.bbrc.2010.03.063 1:CAS:528: DC%2BC3cXks1Kisbk%3D
45. V Everts TJ de Vries MH Helfrich 2009 Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions Biochim Biophys Acta 1792 757 765 19465118 1:CAS:528:DC%2BD1MXpt1OhtLw%3D
46. T Kishi H Hagino H Kishimoto H Nagashima 1998 Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration Bone (NY) 22 515 522 1:CAS:528:DyaK1cXjtVKnu74%3D (Pubitemid 28226866)
47. MR Wilson ME Goddard KP O'Dea S Choudhury M Takata 2007 Differential roles of p55 and p75 tumor necrosis factor receptors on stretch-induced pulmonary edema in mice Am J Physiol Lung Cell Mol Physiol 293 L60 L68 17435079 10.1152/ajplung.00284.2006 1:CAS:528:DC%2BD2sXosV2ls7Y%3D (Pubitemid 47080707)
48. S Balosso T Ravizza C Perego J Peschon IL Campbell MG De Simoni A Vezzani 2005 Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors Ann Neurol 57 804 812 15852477 10.1002/ana.20480 1:CAS:528:DC%2BD2MXlslKksrc%3D (Pubitemid 40798618)
49. S Kondo DN Sauder 1997 Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation Eur J Immunol 27 1713 1718 9247582 10.1002/eji.1830270718 1:CAS:528:DyaK2sXks1Clt7g%3D (Pubitemid 27302854)